鎮痛剤市場

当レポートでは、世界の鎮痛剤市場について調査し、市場の概要とともに、各国の動向、ブランドのケーススタディ、今後の見通しなどを提供しています。

目次

エグゼクティブサマリー

オーストラリア

• 概要
• 規則と分類
• 全身鎮痛薬
• 局所鎮痛薬
• ハーブと天然の関節健康補助食品
• 見通し、予測、機会

ブラジル

カナダ

中国

フランス

ドイツ

インド

イタリア

日本

ポーランド

英国

米国

鎮痛の科学的研究

• 最新の調査結果
• 鎮痛におけるCBDの役割

ブランドのケーススタディ

• ヌロフェン
• パナドール
• タイレノール
• ヴォルタレン

見通し

• 世界市場の予測
• アジア太平洋市場の予測
• 北米市場の予測
• 西欧市場の予測
• ラテンアメリカ市場の予測
• 中欧・東欧市場の予測

Exploring the Current & Future Self-Care Market for Pain Relief

As the global retail market returns to high growth in 2021-22, bouncing back from an historic and coronavirus-driven decline, Analgesics is among the fastest-growing major categories. What are the factors behind this growth and how sustainable are they?

Systemic analgesics have undoubtedly benefited from recommendations for OTC products to treat fever and pain following Covid-19 vaccinations, while resurgence of cold & flu infections has particularly bolstered the children's pain segment. Topical analgesics profited from a post-lockdown return to active lifestyles and corresponding increase in exercise-related pain. Indeed a pandemic-driven shift in lifestyle routines (sedentary habits, increased screen use, stress and shifting sleep patterns) helped drive sales of all pain relief brands.

Meanwhile, Switch has expanded categories in certain markets and NPD fortified selected brands, while several marketers enjoyed success by targeting specific pain niches. Strong A+P investment, as marketer confidence returns, has proved an important growth driver in some areas.

How will marketers take advantage of these new trends? Where can they look for sustained growth or expand their offerings to exploit new niches? What is the next development that helps create dynamism in a mature market?

12 individual markets profiled:

Key Features of this Report:

• An in-depth exploration of the pain relief market, including Systemic analgesics, Topical analgesics and Mouth & dental analgesics, plus coverage of adjacencies such as Herbal & natural joint health supplements

• Coverage of 12 major countries from across the globe, with topline sales, brand performances, latest developments, launches and promotional campaigns

• Very latest MAT Q2 2022 sales from DB6, our dedicated CHC sales database, plus historical growth rates to help chart performance fluctuations

• Category sales segmented by ingredient in each country^†

• Systemic analgesics sales segmented into adults and children's presentations, and Topical analgesics sales split by format and medicated vs non-medicated presentations^†

• Case studies of key Analgesics brands, highlighting success factors, sales, NPD and A+P activity

• Developments in scientific research assessed, including a look at the latest studies surrounding CBD's role in pain relief and promising new ingredients

• A look to the future includes long-term forecast sales for all categories and countries to 2026 & 2031, plus the most up-to-date short-term forecasts to end-2022 & 2023

Key questions investigated in this report:

• What are the key differences from market to market in terms of growth trends, regulations and competitive landscape?

• Which marketers and brands stand out and why?

• How much NPD has the Analgesics market seen and can it drive growth?

• Are new areas to explore signposted by the latest scientific studies?

• Does CBD have a future in pain relief?

• Which gaps in the market still exist and where do opportunities for future growth lie?

By examining 12 core markets in fine detail, analysing brand performances, segment growth and launch activity, our latest Analgesics Report aims to investigate the untapped potential in this dynamic CHC category.

The report features the latest MAT Q2 2022 sales data from our dedicated DB6 database, including topline historical sales globally, by country and category, as well as individual brand performances, and long-term forecasts to 2026 and 2031.

Diving into the factors affecting the Analgesics market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report sheds light on trends & developments across 12 in-depth country profiles (generating 70% of global sales between them) with insights and predictions.

Data analysis within each country profile includes a breakdown of 2021 sales by key ingredient in Systemic analgesics and Topical analgesics. Systemics sales are also divided into adult and children's presentations, while Topicals sales are split by format and medicated vs non-medicated presentations.

The important adjacent category of herbal & natural joint health supplements, where new ingredients are gaining favour, is also investigated.

Assessing the short-term outlook, the report also includes full-year 2022 & 2023 category-level analgesics forecasts in each market profiled.

In-depth coverage of the following categories:

• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements^†

^†sales tracked under VMS in DB6.

With a high degree of launch activity among analgesics, new product development is explored across markets. Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.

The most interesting developments in recent scientific research are rounded up, with a look at promising new ingredients and benefits, while CBD's role in pain relief is also examined.

Table of Contents

Executive Summary

• Global overview
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Switch, innovation & NPD
• Outlook, forecasts & opportunities

Australia

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Brazil

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Canada

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

China

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

France

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Germany

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

India

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Italy

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Japan

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Poland

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

UK

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

USA

• Overview
• Regulations & classifications
• Systemic analgesics
• Topical analgesics
• Mouth & dental analgesics
• Herbal & natural joint health supplements
• Outlook, forecasts & opportunities

Scientific Studies in Pain Relief

• Latest findings
• CBD's role in pain relief

Brand Case Studies

• Nurofen
• Panadol
• Tylenol
• Voltaren

Outlook

• Global forecast
• Asia-Pacific forecast
• North America forecast
• Western Europe forecast
• Latin America forecast
• C&E Europe forecast